Real-world experience with idarucizumab for the reversal of dabigatran has highlighted the importance of monitoring coagulation tests particularly in patients with renal impairment. Speaking at Blood 2018, final year haematology registrar Dr Yvonne Brennan reported on a retrospective audit of idarucizumab use and clinical outcomes in Western Sydney Local Health District. The audit involved 24 ...
Lessons from local idarucizumab use
By Mardi Chapman
26 Oct 2018